IDXG says its testing is made available to its members by its strategic partner, LabCorp, Independence’s primary lab services provider, through LabCorp’s Dianon Pathology specialty laboratory.
IDXG’s tests for thyroid cancer are designed for patients whose initial thyroid nodules biopsy is indeterminate, without a conclusive indication of whether the nodule is malignant or benign.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.